Next-generation sequencing (NGS), massively parallel or deep sequencing is a related term describing DNA sequencing technology that has revolutionized genome research. The development of sequencing-based chromatin analysis technology allows current researchers to experimentally measure the properties of chromatin. NGS is the choice for large-scale genome and transcriptome sequencing. This is because the high-throughput sequencing data generated and output by each instrument is in the gigabyte range, and the cost is compared with the traditional Sanger first-generation sequencing method.
The difference between NGS technology and Sanger method is that they provide large-scale parallel analysis, which can provide ultra-high throughput of multiple samples at a greatly reduced cost. Millions to billions of DNA nucleotides can be sequenced in parallel, which significantly increases yields and minimizes the need for fragment cloning methods used in Sanger Sequencing.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States